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Since 1989, human immunodeficiency virus type 1 (HIV-1) has spread explosively through the heterosexual
population in Thailand. This epidemic is caused primarily by viruses classified as “subtype E”, which, on the
basis of limited sequence comparisons, appear to represent hybrids of subtypes A (gag) and E (env). However,
the true evolutionary origins of “subtype E” viruses are still obscure since no complete genomes have been
analyzed, and only one full-length subtype A sequence has been available for phylogenetic comparison. In this
study, we determined full-length proviral sequences for “subtype E” viruses from Thailand (93TH253) and the
Central African Republic (90CR402) and for a subtype A virus from Uganda (92UG037). We also sequenced
the long terminal repeat (LTR) regions from 16 virus strains representing clades A, C, E, F, and G. Detailed
phylogenetic analyses of these sequences indicated that “subtype E” viruses do indeed represent A/E recom-
binants with multiple points of crossover along their genomes. The extracellular portion of env, parts of vif and
vpr, as well as most of the LTR are of subtype E origin, whereas the remainder of the genome is of subtype A
origin. The possibility that the discordant phylogenetic positions of “subtype E” viruses in gag- and env-derived
trees are the result of unusual rates or patterns of evolution was also considered but was ruled out on the basis
of two lines of evidence: (i) phylogenetic trees constructed for synonymous and nonsynonymous substitutions
yielded the same discordant branching orders for “subtype E” gag and env gene sequences, thus excluding
selection-driven evolution, and (ii) multiple crossovers in the viral genome are most consistent with the copy
choice model of recombination and have been observed in other documented examples of HIV-1 intersubtype
recombination. Thai and CAR “subtype E” viruses exhibited the same pattern of A/E mosaicism, indicating
that the recombination event occurred in Africa prior to the spread of virus to Asia. Finally, all “subtype E”
viruses were found to contain a distinctive two-nucleotide bulge in their transactivation response (TAR)
elements. This feature was present only in viruses which also contained a subtype A 5* pol region (i.e., subtype
A viruses or A/D and A/E recombinants), raising the possibility of a functional linkage between the TAR region
and the polymerase. The implications of epidemic spread of a recombinant HIV-1 strain to viral natural history
and vaccine development are discussed.
Genetic diversity is a hallmark of human immunodeficiency
virus type 1 (HIV-1) biology and poses a major obstacle to both
drug and vaccine development (6, 32, 54, 69, 76, 84, 95). Sev-
eral factors are known to contribute to the generation of new
variants and influence the speed with which these viruses
evolve. One is the error-prone nature of the viral reverse trans-
criptase (RT), which lacks proofreading functions and intro-
duces substitutions at a rate of approximately 3 3 1025 nucle-
otide changes per site per replication cycle (64). A second
factor is the high rate of virus production (up to 1010 virions
per day) and the large numbers of replication cycles (approx-
imately 300 per year) that sustain HIV-1 infection in vivo (12,
38, 83, 110). A third factor is in vivo selection pressure, which,
for example, is responsible for the rapid emergence of drug-
resistant viral escape mutants (110). Together, these mecha-
nisms generate viral variants at extraordinary rates (12) and
represent a major force driving HIV-1 evolution in infected
populations worldwide. However, recent evidence suggests
that recombination among highly divergent HIV-1 strains oc-
curs quite frequently, indicating that this process may also
contribute importantly to HIV-1 diversification (15, 16, 25, 56,
85, 86, 88, 91, 99).
Recombination is a fundamental property of retroviruses
resulting from their dimeric RNA genome and an RT that can
switch between templates during proviral DNA synthesis (10,
31, 40, 41, 47, 105). In fact, it has been suggested that recom-
bination is a necessary component of the viral replication strat-
egy, since breaks in either of the two RNA molecules are
common (the forced copy choice model proposed by J. Coffin
[10]). In this process, the RT switches between heterozygous
RNA templates as DNA synthesis proceeds. As the number of
crossovers increases, so does the complexity of the resulting
hybrid genome. Until recently, recombination in HIV-1 was
thought to involve only the closely related members of the
quasispecies that evolve within infected individuals over time
(14, 33, 39, 90, 108). However, analysis of sequences submitted
to the HIV-1 database indicates that recombination also occurs
between highly divergent strains of HIV-1 (34, 91, 99), thus
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raising the possibility that HIV-1 variants can acquire biolog-
ically important traits through exchange of genetic material.
Globally circulating strains of HIV-1 have been classified on
the basis of their phylogenetic relationships into genetic groups
(termed M and O) and subtypes (A to I) (51, 61, 75, 96). The
great majority of these viruses appears to have evolved in a
clonal fashion, because evolutionary trees derived from differ-
ent regions of their genomes exhibit consistent branching or-
ders (75, 96). However, recent phylogenetic studies of HIV-1
group M viruses have identified a surprising number of strains
which cluster in different sequence subtypes depending on
which part of the genome is analyzed (16, 25, 56, 58, 85, 86, 88).
This finding, along with the fact that all of these viruses orig-
inated from geographic regions where the same divergent se-
quence subtypes are known to cocirculate, strongly suggests
that these viruses are the product of recombination events.
Consistent with the copy choice and other models of recombi-
nation (11), most of these hybrid viruses exhibit complex ge-
nome structures characterized by multiple crossovers (85, 86).
Virus strains representing all of the major HIV-1 group M
subtypes have been found to be involved in these recombina-
tion events (86). Intersubtype recombinant viruses have been
identified in primary patient material (25, 88), in sequential
isolates obtained from infected individuals over time (25, 93),
and in heterosexual transmission pairs (56, 88, 93). Taken
together, these results suggest that intersubtype recombination
may be a relatively common occurrence in populations expe-
riencing epidemic spread and intermixing of multiple sequence
subtypes (97).
One of the most interesting and clinically important exam-
ples of potential HIV-1 recombinants are the so-called “sub-
type E” viruses, which are most prevalent in Thailand and
neighboring countries in Southeast Asia (111, 112). Having
been introduced into Thai populations relatively late in the
global epidemic (between 1988 and 1989), these viruses spread
rapidly and through largely heterosexual transmission routes
(46, 52, 77, 79, 100, 109). Of the 750,000 individuals estimated
to be infected with HIV-1 in Thailand to date, about 90% are
thought to harbor members of “subtype E” (13, 111). At the
genetic level, Thai “subtype E” viruses are all highly related to
each other, presumably reflecting a founder effect (67, 80).
They are also related to the more heterogeneous “subtype E”
viruses from the Central African Republic (CAR viruses) and
Cameroon (72, 78), suggesting that the African viruses repre-
sented the source of infection for the Thai epidemic (72, 73).
Evidence that both Thai and CAR “subtype E” viruses may
represent recombinants has been derived from phylogenetic
studies of gag and env regions (62, 67, 72, 96). In the extracel-
lular portion of gp120 and gp41, “subtype E” viruses have long
been known to cluster as a distinct group, a finding which led
to their initial classification as an independent subtype (74). In
contrast, in the gag region, all “subtype E” viruses thus far
characterized fall within the subtype A radiation (62). The
simplest explanation for these discordant branching orders is
that “subtype E” viruses are the descendants of a hybrid
HIV-1, generated by recombination between members of sub-
types A and E (25, 86, 96). However, the absence of a gag
subtype E equivalent, as well as the lack of sequence informa-
tion in regions other than gag and env, have left the phyloge-
netic origins of “subtype E” viruses open to question.
To elucidate the evolutionary history of “subtype E” viruses,
we have cloned and characterized full-length proviral se-
quences from two isolates, one from Thailand (93TH253) and
the other (90CR402) from the Central African Republic. Us-
ing a variety of methodologies, we have investigated their phy-
logenetic subtype assignments in different parts of the genome
and have examined whether their discordant branching orders
for gag and env gene sequences could be the result of unusual
patterns of gene evolution rather than recombination. Our
results indicate that “subtype E” viruses do indeed represent
A/E intersubtype recombinants. Moreover, comparison of the
CAR and Thai strains indicates that they are derived from a
common A/E recombinant ancestor, presumably originating in
Central Africa, where both subtype A and the parental (non-
recombinant) subtype E must have coexisted (72, 78). These
data thus indicate that intersubtype recombination can gener-
ate virulent HIV-1 strains which have the capacity to signifi-
cantly influence the course of the global AIDS epidemic.
MATERIALS AND METHODS
Virus isolates. All virus isolates used for sequence comparisons in this study
have been described previously (72, 113, 114) and are listed according to World
Health Organization nomenclature, denoting the year of isolation, the country of
origin (two-letter code), and the isolate number (50). 92RW020, 92UG031,
92UG037, 92BR025, 93MW959, 93MW960, 93MW965, 92TH006, 92TH022,
93TH976, 93TH966, 93BR019, 93BR020, and 93BR029 were obtained from
World Health Organization and National Institutes of Allergy and Infectious
Diseases-sponsored Networks for Virus Isolation and Characterization and rep-
resent primary HIV-1 isolates from asymptomatic individuals early in infection
(25, 26, 113). 92UG975 and 93RU131 were derived from two AIDS patients with
subtype G infections who originated from Uganda and Russia, respectively (5,
45). 90CR402 (previously also termed CAR-E 4002) was obtained from an
African man who presented with lymphadenopathy, diarrhea, severe weight loss,
and recurrent respiratory infections at the University Hospital in Bangui, Central
African Republic (72). 93TH253 (previously termed CMU010 or 302053) was
isolated from a Thai patient with end-stage AIDS who was hospitalized at Chiang
Mai University Medical Center (114). Subtype designation was made on the basis
of partial or complete env gene sequences (72, 113, 114). All isolates were
established and subsequently propagated by cocultivation with normal donor
lymphocytes (72, 113, 114), except for 90CR402, which was passaged in chim-
panzee peripheral blood mononuclear cells (PBMCs) (22), and 93TH253, which
was adapted to growth in immortalized human T-cell lines (unpublished data).
For lambda phage cloning, isolates 90CR402 and 93TH253 were expanded in
human PBMCs and H9 cells, respectively.
Southern blot analysis. Productively infected 90CR402 (PBMC) and 93TH253
(H9) cultures were amplified by addition of uninfected target cells, monitored for
RT activity, and harvested (2 3 108 cells) at peak virus replication. Cells were
washed extensively in Hanks balanced salt solution, lysed in 10 ml of lysing buffer
(10 mM Tris-HCl [pH 7.5], 5 mM EDTA, 0.5% sodium dodecyl sulfate) con-
taining proteinase K (100 mg/ml), and incubated at 378C overnight. High-molec-
ular-weight DNA was extracted twice with phenol-chloroform (1:1) and once
with chloroform, precipitated with 2 volumes of absolute ethanol, and dissolved
in TE buffer (10 mM Tris-HCl [pH 7.6], 1 mM EDTA). Then 10 mg of culture
DNA was digested with restriction endonucleases, separated by electrophoresis
on a 0.7% agarose gel, blotted onto nitrocellulose filters, hybridized to a 32P-
labeled full-length HIV-1 probe (BH10 [35]), and exposed to X-ray film as
described previously (63). The resulting autoradiogram was used to estimate the
relative abundance of integrated and unintegrated viral DNA and to identify
restriction enzymes suitable for lambda phage cloning (63).
Lambda phage cloning of full-length HIV-1 proviruses. Genomic lambda
phage libraries were constructed and screened as described previously (29, 59,
98). Briefly, high-molecular-weight DNA from productively infected cultures was
digested with an appropriate cloning enzyme (BamHI for isolate 90CR402;
EcoRI for isolate 93TH253), fractionated by sucrose gradient centrifugation to
enrich for fragments 15 to 22 kb in length, and ligated into purified arms of
lDASHII (Stratagene, La Jolla, Calif.). Ligation products were packaged in vitro
(Gigapack II Gold; Stratagene), titered, and plated on LE392 cells. Recombinant
phage clones (20,000 plaques per plate) were screened with a full length HIV-1
probe (BH10 [35]). Positive phage recombinants were plaque purified, and their
restriction maps were determined by multiple enzyme digestions. Phage clones
containing complete (integrated) HIV-1 proviruses were digested with restriction
enzymes, and their inserts were subcloned into appropriate plasmid vectors
(digestion of l93TH253.3 with EcoRI released a 15.2-kb insert which was sub-
cloned into pTZ18R; digestion of l90CR402.1 with BamHI released a 17.8-kb
insert which was subcloned into pSP72).
DNA transfection and viral infectivity studies. Plasmid subclones of lambda
phage-derived (full-length) HIV-1 proviruses were transfected into 293T or
COS-1 cells by the calcium phosphate precipitation method (3). Sixty hours
posttransfection, culture supernatants were analyzed for RT activity, filtered, and
used to infect CD4-bearing target cells (primary PBMCs and T-cell lines). Cul-
tures were monitored weekly for RT activity and maintained for 2 months.
Transfection-derived virus preparations were also examined by Western blot
(immunoblot) analysis as described previously (60).
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Amplification of near-complete HIV-1 proviruses using long-PCR methods.
Amplification of a near-full-length provirus from isolate 92UG037 was per-
formed by using the long-PCR procedure (GeneAmp XL kit; Perkin-Elmer
Cetus, Foster City, Calif.) according to the manufacturer’s instructions. Primers
were designed to amplify HIV-1 proviral sequences between the tRNA primer
binding site (primer UP1A, 59-AGTGGCGCCCGAACAGG-39) and the
poly(A) signal in the 39 long terminal repeat (LTR) (primer LOW2, 59-TGAG
GCTTAAGCAGTGGGTTTC-39). Cycling conditions included a hot start (2
min, 948C), then 20 cycles of denaturation (948C) for 30 s and extension (688C)
for 10 min, and then 17 cycles of denaturation (948C) for 30 s and extension
(688C) for 10 min, with 15-s increments per cycle. PCR products were visualized
by agarose gel electrophoresis and subcloned into pCRII by T/A overhang.
Transformations were performed in TG-1 cells. Colonies were screened by re-
striction enzyme digestion for full-length inserts.
Sequencing of HIV-1 proviruses. Nucleotide sequences of full-length (or near-
full-length) HIV-1 proviruses were determined by the shotgun sequencing ap-
proach as described previously (65). Briefly, recombinant phage or plasmid
inserts containing a complete provirus were purified by gel electrophoresis and
sonicated (model XL2020 sonicator; Heat Systems Inc., Farmingdale, N.Y.) to
generate randomly sheared DNA fragments 600 to 1,000 bp in length. Following
isolation and purification by gel electrophoresis, fragments were end repaired by
using T4 DNA polymerase and Klenow enzyme (65), and blunt-ended DNA
fragments were then ligated into M13 or pTZ18R cleaved with SmaI and de-
phosphorylated with calf intestinal alkaline phosphatase to reduce vector self-
ligation. pTZ18R colonies or M13 phage plaques were screened by hybridization
with a full-length HIV-1 probe (BH10 [35]). Positive colonies or plaques were
picked, and vectors were grown by using standard methods (63). Sequence
analysis was performed by using cycle sequencing and dye terminator method-
ologies on an automated DNA Sequenator (model 373A; Applied Biosystems,
Inc.) according to the manufacturer’s recommendations. On average, 200 shot-
gun clones per provirus were sequenced. Proviral contigs were assembled from
individual sequences by using the Sequencher program (Gene Codes Corpora-
tion, Ann Arbor, Mich.). Small gaps were filled in by direct sequencing of the
cloned provirus, using strain-specific sequencing primers. Sequences were deter-
mined for both strands of DNA.
Sequence analysis. Sequences were analyzed by using Eugene (Baylor College
of Medicine, Houston, Tex.), PIMA (101, 102), and MASE (17). Secondary RNA
structures of transactivation response (TAR) elements were predicted and plot-
ted by using the programs MFold and PlotFold from the University of Wisconsin
Genetics Computer Group software package (version 8).
PCR amplification of LTR sequences.A 670-bp fragment spanning most of the
viral LTR was amplified from cultured PBMC DNA of isolates representing
subtypes A (92RW020, 92UG031, and 92UG037), C (92BR025, 93MW959,
93MW960, and 93MW965), E (92TH006, 92TH022, 93TH976, and 93TH966), F
(93BR019 and 93BR029), and G (92RU131 and 92UG975). PCR amplifications
were performed with primers LTR A (59-CAAGGATCCTTCCCTGATTGGC
AGAACTAC-39) and PBS B (59-CTTAATACTGACGCTCTCGCACCCAT-39) in
the first round and LTR A and PBS D (59-CTCTCCTTCTAGCCTCCGCTAGTC-
39) in the second round in a seminested approach (denaturing at 948C for 1 min,
annealing at 558C for 1 min, and extension at 728C for 1 min; 30 cycles). Amplified
fragments were sequenced directly (without prior subcloning), using cycle sequenc-
ing and dye terminator methodologies as described above.
Phylogenetic tree constructions. Phylogenetic relationships of newly derived
viral sequences were estimated from comparisons with those of previously re-
ported representatives of HIV-1 group M. Nucleotide sequences were aligned by
using CLUSTAL (37), with minor manual adjustments, bearing in mind the
predicted protein sequences. Pairwise evolutionary distances were estimated by
using Kimura’s two-parameter method (49) to correct for superimposed substi-
tutions; sites where there was a gap in any sequence and ambiguous areas in the
alignments were excluded from all comparisons. Distances were also calculated
for synonymous and nonsynonymous substitutions separately, using Li’s method
(57). Phylogenetic trees were constructed by the neighbor-joining method (89),
and their reliability was estimated from 1,000 bootstrap replicates (18). These
methods were implemented by using CLUSTALW (106) and programs from the
PHYLIP package (19).
Nucleotide sequence accession numbers. GenBank accession numbers for the
full-length HIV-1 proviral sequences reported in this study are U51188
(90CR402.1), U51189 (93TH253.1), and U51190 (92UG037.1). LTR sequences
are available under accession numbers U51282 to U51297.
RESULTS
Lambda phage cloning of full-length “subtype E” proviruses
from Thailand and the Central African Republic. Full-length
“subtype E” proviral genomes were cloned to investigate their
genomic organization and phylogenetic origins and to generate
reference reagents useful in vaccine development. For this
purpose, we selected two isolates, one (93TH253) representa-
tive of strains currently spreading epidemically in Thailand
(114) and the other (90CR402) representative of strains from
Central Africa that are believed to have been the source of the
Thai epidemic (72). In addition, 90CR402 was chosen because
it constitutes a highly cytopathic strain which grows to high
titers in both human and chimpanzee PBMCs (3a, 22) and thus
has been used as a challenge strain in chimpanzee vaccination
and superinfection studies (23). Both isolates were initially
classified as “subtype E” on the basis of V3 loop sequences (72,
114).
We selected a lambda phage cloning approach to obtain
full-length “subtype E” genomes because this method allows
the cloning of complete proviruses as single genomic units (29,
59, 63, 98) and avoids the possibility of PCR artifacts due to
misincorporation of nucleotides or other polymerase-related
errors. Lambda phage cloning requires higher proviral loads
than PCR approaches and thus depends on efficient viral
growth in culture. Figure 1A depicts a Southern blot of isolates
90CR402 and 93TH253 grown in PBMCs and H9 cells, respec-
tively, and illustrates the low quantities of proviral DNA that
we routinely observed in “subtype E”-infected PBMC cultures.
Of several “subtype E” isolates analyzed, 90CR402 replicated
by far the best in primary PBMC cultures. Three other Thai
isolates (including 93TH253) replicated poorly despite multi-
ple passages and frequent addition of uninfected target cells.
Because the proviral DNA content in these cultures was insuf-
ficient for lambda phage cloning purposes (data not shown),
we selected H9-propagated 93TH253, along with PBMC-
grown 90CR402, for the construction of genomic libraries.
Restriction enzyme analysis of proviral DNA identified
BamHI and EcoRI as suitable (no-cutter) cloning enzymes for
90CR402 and 93TH253, respectively (data not shown). Geno-
mic DNA was digested to completion and ligated into purified
arms of lDASHII. Libraries were titered and screened with a
full-length (subtype B) HIV-1 probe (35). For 93TH253, screen-
ing of 2 3 105 recombinant phage clones was sufficient to yield
three positive recombinants (only one clone, 93TH253.3, was
further analyzed). For 90CR402, 1.2 3 107 plaques (600 plates
with 20,000 plaques per plate) had to be screened to identify
a single positive HIV-1 recombinant (termed 90CR402.1).
Phage clones were plaque purified and analyzed by restric-
tion enzyme analysis, which indicated the positions of the
proviruses relative to their flanking cellular sequences (Fig.
1B).
Biological activity of lambda phage-derived “subtype E”
proviruses. To test their replication competence, plasmid sub-
clones containing the full-length 90CR402.1 and 93TH253.3
genomes were transfected into 293T cells and COS-1 cells.
Positive RT activity in the supernatants of transfected cell
cultures indicated that both clones were expressing gag, tat, rev,
and pol genes. Western blot analysis confirmed the presence of
gag and pol gene products but failed to confirm the expression
of envelope glycoproteins in supernatants from cells trans-
fected with 93TH253.3 (data not shown). Subsequent coculti-
vation of transfected cells with normal donor PBMCs and
immortalized T-cell lines did not result in the establishment of
productively infected cultures for either clone. These results
indicated that both 90CR402.1 and 93TH253.3 proviruses are
replication defective.
Sequence analysis of “subtype E” proviruses.Both 90CR402.1
and 93TH253.3 proviruses were sequenced in their entirety.
Analysis of their genomic organization revealed the presence
of complete 59 and 39 LTRs and nine potential open reading
frames corresponding to gag, pol, vif, vpr, tat, rev, vpu, env, and
nef genes (Fig. 1C). There were no major deletions or rear-
rangements in either provirus, but in-frame stop codons were
found in the vif gene of 90CR402.1 and the env gene (gp41-
encoding portion) of 93TH253.3. Each of these mutations
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could explain the failure of these clones to establish a produc-
tive infection in primary PBMCs. 90CR402.1 also failed to
replicate in T-cell lines known to be permissive for vif-deficient
viruses (60), e.g., SupT1 and CEMx174 (data not shown). This
may be due to a restricted cell tropism mediated by the viral
envelope gene products rather than additional mutations, since
primary isolates frequently fail to infect immortalized T-cell
lines. Both 93TH253.3 and 90CR402.1 also lacked the vpu
initiation codon, which is not required for virus replication;
mutations at this codon are frequently seen after in vitro cul-
ture (29, 59, 75).
Phylogenetic analyses of “subtype E” env and gag regions.
The phylogenetic relationships of the new “subtype E” viruses
were first examined in evolutionary trees of gag and env gene
sequences (Fig. 2). As expected, 90CR402.1 and 93TH253.3
clustered with “subtype E” viruses from Thailand in both
genomic regions. Furthermore, their phylogenetic positions
relative to the other “subtype E” viruses were consistent with
their geographic origins. 93TH253.3 fell just outside the cluster
of previously characterized Thai viruses, while 90CR402.1
branched well outside the same cluster. The overall extent of
divergence among the Thai viruses (including 93TH253.3) was
relatively low, consistent with the founder effect previously
proposed for Thai “subtype E” isolates (67, 80). In contrast,
the divergence between the Central African strain 90CR402.1
and the Thai “subtype E” viruses was much greater and com-
parable to that typically seen between epidemiologically unre-
lated strains within other clades (73, 96). These results thus
support the conclusion that “subtype E” viruses have evolved
in Central Africa for some period of time prior to their intro-
duction into the Thai population (72, 78).
As in previous analyses (62, 67), the new “subtype E” viruses
formed a distinct clade in the env tree but fell within the
subtype A radiation in the gag tree (Fig. 2). This difference in
phylogenetic position is quite remarkable and contrasts with
that of two subtype A viruses, U455 and DJ258, which are
shown in the same trees (Fig. 2). These latter two viruses,
although themselves quite divergent, nonetheless occupy sim-
ilar positions within clade A in both gag and env regions. In the
gag tree, “subtype E” viruses, U455, and DJ258 are all approx-
imately equidistantly related; i.e., the three branches leading to
the “subtype E” viruses, the DJ258 group (which includes, for
example, CI51), and the U455 cluster (which includes, for
example, VI59), form a trichotomy. In contrast, in the env tree
“subtype E” viruses branch off far outside the A clade and long
before the divergence of U455 and DJ258. This difference in
phylogenetic position of “subtype E” gag and env sequences is
quite striking and highly suggestive of recombination (85, 86).
Diversity and bootstrap plots. Except for viruses of subtype
B, sequence information outside of gag and env regions is
extremely limited. Only six complete non-subtype B viruses
have been sequenced thus far: one subtype A strain (U455),
three subtype D strains (NDK, Z2Z6, and ELI), and two in-
tersubtype recombinants (MAL and IBNG; see below) (75).
Full-length reference sequences are not available for the other
subtypes, thus making subtype assignments in LTR, pol, or
accessory gene regions problematic. To characterize the newly
derived “subtype E” viruses in regions outside the gag and env
regions, we therefore examined which parts of their genomes
were distantly, and which were closely, related to subtype A.
This was done by aligning the sequences of 93TH253.3 and
U455 (as representatives of “subtype E” and subtype A) and
plotting their divergence along the genome (Fig. 3A). Distance
values were calculated for a window of 500 nucleotides which
FIG. 1. Molecular cloning of full-length “subtype E” proviruses. (A) Southern blot of PBMC and H9 cultures productively infected with isolates 90CR402 and
93TH253, respectively. Total genomic DNA was digested with NheI and HindIII (both of which cleave the viral LTR) and probed with a full-length HIV-1 clone. The
size of the resulting restriction fragments is indicated. (B) Schematic representation of full-length lambda phage clones containing the 93TH253.3 and 90CR402.1
genomes, respectively. Restriction enzyme cleavage sites used for cloning (BamHI and EcoRI) and Southern blot analysis (A) are shown. Cellular sequences flanking
the integrated provirus are denoted by wavy lines. (C) Organization of the “subtype E” genome. Open reading frames were identified using the program FRAMES
of the University of Wisconsin Genetics Computer Group package. Stop codons, including two within coding regions, are indicated by vertical lines.
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was moved in steps of 10 nucleotides (the “E”-A distance). For
comparison, similar plots were also generated for 93TH253.3
and LAI (the “E”-B distance), as well as for 93TH253.3 and
90CR402.1 (the “E”-“E” distance). Importantly, all sequences
were aligned according to their predicted amino acid se-
quences, and distance values were calculated after removal of
all gaps from the alignments.
As expected, the extent of divergence between the two “sub-
type E” viruses (90CR402.1 in Fig. 3A) varied along the ge-
nome, with the envelope region reaching the highest values.
Predictably, the distance between 93TH253.3 and the clade B
virus LAI was much higher, but more importantly, it generally
followed the variation in distance between the two “subtype E”
strains (i.e., the same regions exhibited proportionately higher
or lower levels of divergence). In contrast, the extent of diver-
gence between 93TH253.3 and U455 varied disproportionately
along the genome. For the most part, this “E”-A distance was
intermediate (i.e., the U455 plot fell between the 90CR402.1
and the LAI plots), which is consistent with the evolutionary
relationships seen in gag (Fig. 2A), where “subtype E” viruses
fall within subtype A. However, there were regions where the
“E”-A distance matched or even exceeded the “E”-B distance
(i.e., the U455 plot moved closer to or even above the LAI
plot). This reflects the evolutionary relationships in env (Fig.
2B), where “subtype E” viruses are distinct from subtype A.
Thus, noting the points in Fig. 3A at which the “E”-A distance
increased or decreased relative to the “E”-“E” and “E”-B
distances allowed the tentative identification of breakpoints in
the putative E/A recombinants. For example, at position 5500
(the 59 end of env), the LAI plot fell whereas the U455 plot did
not, and both plots crossed around site 5800. Bearing in mind
the window size of 500 nucleotides, this finding suggests that a
crossover occurred in the region from positions 5500 to 5800.
Similarly, at position 4700 (within vif), the U455 plot rose
relative to the 90CR402.1 plot, suggesting that in this region
93TH253.3 is E-like rather than A-like.
To augment these analyses, we examined further the phylo-
genetic positions of the two “subtype E” viruses in relationship
to U455. Trees were constructed for 90CR402.1, 93TH253.3,
U455, two subtype B strains (LAI and RF), and two subtype D
strains (NDK and Z2Z6), using simian immunodeficiency virus
SIVCPZGAB as an outgroup; then the magnitude of the boot-
strap value supporting the clustering of “subtype E” viruses
with subtype A (i.e., the bootstrap value for the branch marked
FIG. 2. Phylogenetic relationships of “subtype E” gag (A) and env (B) sequences in comparison to representatives of other HIV-1 group M subtypes (see the text
for a description of the methodology). Horizontal branch lengths are drawn to scale (the scale bar represents 0.02 nucleotide substitutions per site); vertical separation
is for clarity only. Values at nodes indicate the percentage of bootstraps in which the cluster to the right was found (bootstrap values of 75% and higher are shown).
An arrow indicates the branch that leads to the A/E cluster in gag and env phylogenies. Asterisks denote two divergent subtype A viruses (U455 and DJ258) referred
to in the text. Brackets at the right represent the major sequence subtypes of HIV-1 group M. The 39 end of env (encoding the membrane-spanning and
intracytoplasmatic domains) was excluded from the analysis since “subtype E” and “subtype G” viruses are known to be recombinant in this region (25). Trees were
rooted by using SIVCPZGAB as an outgroup.
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by an arrow in Fig. 2) was examined. On the basis of the
phylogenies depicted in Fig. 2, we expected regions of “subtype
E” viruses which were of subtype A origin to yield very high
(.90%) bootstrap values. Alternatively, regions of true sub-
type E origin were expected to have very low (,50%) values.
Figure 3C depicts the results of more than 80 such phyloge-
netic analyses, each performed on a window of 500 nucleo-
tides, moved in steps of 100 nucleotides (this approach is
similar to the “bootscanning” method of Salminen et al. [92]).
Very high bootstrap values (.90%) are found for much of the
“subtype E” genome, indicating that gag, pol, vpr/vpu, and 59
nef regions actually derive from subtype A. The plot also illus-
trates regions where “subtype E” viruses did not cluster con-
sistently with U455, which, as expected, included the envelope.
However, there was a second well-defined area with very low
bootstrap values (between positions 4200 and 4900), suggesting
that sequences in the vif region also represent subtype E.
Recombination breakpoint analysis using a second subtype
A reference sequence. Because all conclusions drawn from Fig.
3A and C depend on the assumption that U455 is itself not a
recombinant, it was necessary to evaluate the diversity and
bootstrap plots by using a second (independent) subtype A
reference strain. We thus used long-PCR methods (94) to
amplify a near-full-length genome of 92UG037 [between the
tRNA primer binding site and the poly(A) signal of the 39
LTR]. This isolate has previously been reported to represent
subtype A (25). The LTR region, which was not included in the
long PCR fragment, was independently amplified by regular
PCR. Sequence analysis of both fragments allowed the recon-
struction of the entire proviral sequence, which was then used
to map potential recombination breakpoints in 90CR402.1 and
93TH253.3, as described above (a more detailed description of
the 92UG037.1 sequence is provided elsewhere [24]). Diversity
and bootstrap plots using 92UG037.1 as the subtype A refer-
FIG. 3. Diversity and bootstrap plots comparing the sequence relationships among members of subtypes A, “E,” and B. (A) Sequence divergence between
93TH253.3 and LAI (“E”-B distance), 93TH253.3 and U455 (“E”-A distance), and 93TH253.3 and 90CR402.1 (“E”-“E” distance). Distance values were calculated for
a window 500 nucleotides moved in steps of 10 nucleotides. The x axis indicates the nucleotide positions along the alignment (gaps were stripped and removed from
the alignment). The beginning of gag, pol, vif, vpr, env, and nef open reading frames are shown. The y axis denotes the distance between the viruses compared (0.05 5
5% divergence). (B) Diversity plot generated as for panel A but with 92UG037.1 used in place of U455 as the reference sequence for subtype A. (C) Bootstrap plots
illustrating the likelihood of clustering of “subtype E” viruses (90CR402.1 and 93TH253.3) with subtype A. Trees were constructed for 90CR402.1, 93TH253.3, U455,
two subtype B strains (LAI and RF), and two subtype D strains (NDK and Z2Z6), using SIVCPZGAB as an outgroup. The magnitude of the bootstrap value supporting
the clustering of “subtype E” viruses with subtype A is reported for windows of 500 nucleotides moved in steps of 100 nucleotides. Regions of the “subtype E” genome
which are of subtype A origin exhibit very high (.90%) bootstrap values. Regions of subtype E origin are characterized by very low (,50%) values. The x axis is as
in panel A; the y axis indicates the percentage of bootstrap replicates supporting the clustering of “subtype E” viruses with subtype A. (D) Bootstrap plot as in panel
C except using 92UG037.1 as a subtype A reference sequence in place of U455.
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ence sequence were very similar to those using U455 (Fig. 3,
compare panels A and C with panels B and D), suggesting that
neither U455 nor 92UG037.1 was recombinant. Again, boot-
strap values were low in vif and env regions, although the
length of the env portion differed slightly between the two
plots. In the U455 bootstrap plot, this area extended from
positions 5800 to 7500, while the same region mapped between
position 5500 and 7000 in the 92UG037.1 plot (compare Fig.
3C and D). The exact points of crossover delineating the sub-
type E env region are thus uncertain.
Phylogenetic analysis of “subtype E” pol, vif, tat/vpu, and 5*
nef regions. To further characterize the putative A and E
portions within the “subtype E” genome, we determined phy-
logenies for partial gene sequences including as many repre-
sentatives of additional subtypes as were available from the
most recent HIV sequence database release (75). As suggested
by the diversity and bootstrap plots, pol sequences of the “sub-
type E” viruses clustered within subtype A (Fig. 4). This was
the case for the entire pol regions of both 90CR402.1 and
93TH253.3 and was supported by 100% bootstrap values. Se-
quences from 59 tat/vpu and 39 nef domains of “subtype E” also
clustered well within the subtype A radiation, again confirming
results from the diversity and bootstrap plots. Subtype assign-
ment in the vif region, however, was more difficult. From the
diversity and bootstrap plots, we expected that “subtype E”
viruses would not cluster within subtype A in this region. This
was indeed the case. In a tree of vif sequences downstream of
the vif/pol overlap (not shown), “subtype E” sequences fell
outside the subtype A radiation, although not as far outside as
previously seen for env sequences. Moreover, inspection of the
bootstrap plots indicated a small additional A peak at position
4500 in both Fig. 3C and Fig. 3D, suggesting that within this
region “subtype E” viruses are multiply mosaic. To investigate
this possibility, we constructed phylogenetic trees from vif se-
quences excluding short regions (of 100 bp) at different posi-
tions in the alignment. These analyses yielded one tree (de-
rived from sequences between positions 57 and 579 of the vif
alignment but excluding positions 351 to 450) in which “sub-
FIG. 4. Phylogenetic relationships of the newly derived “subtype E” viruses in pol, vif, 59 tat plus vpu, and 59 nef regions. See the text and the legend for Fig. 2 for
details.
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type E” viruses fell significantly outside subtype A (Fig. 4, vif),
thus strongly suggesting that vif contains an additional short A
portion just before the vpr overlap.
Phylogenetic analyses of LTR sequences. To examine the
subtype assignment of the “subtype E” LTR region, it was
necessary to generate reference sequences for several different
HIV-1 group M subtypes for which such information was un-
available. Using regular PCR, we amplified a 670-bp fragment
spanning most of U3, R, and U5 from a panel of primary
isolates previously reported to represent subtypes A, C, E, F,
and G on the basis of env sequences (25, 26). A total of 16 new
viral LTR sequences (in addition to 93TH253.3 and
90CR402.1) were then determined (also see Fig. 8) and phy-
logenetically analyzed. Thirteen of these sequences are shown
in Fig. 5. Amplification products were sequenced directly with-
out interim cloning, and a phylogenetic tree was constructed
from 59 LTR sequences (between positions 93 and 548 of the
alignment [Fig. 5]). Reference sequences for subtype B and D
viruses were obtained from the database. Importantly, this tree
depicts an overall topology for the various HIV-1 group M
subtypes that is very similar to topologies previously obtained
from sequences of coding regions (e.g., compare Fig. 5 with gag
and env trees shown in Fig. 2). That is, viruses known to cluster
together in a particular subtype according to gag or env (e.g.,
viruses belonging to subtype C or F) formed the same distinct
groupings in the LTR tree. Even the closer relationship of
subtypes B and D viruses previously reported for gag, pol, or
env phylogenies (96) is represented in the LTR tree. These
results suggest that LTR sequences can be used reliably for
subtype classification.
As shown in Fig. 5, “subtype E” LTR sequences formed a
distinct lineage, separate from all other clades, including A,
and similar to the one identified for “E” env sequences (Fig.
2B). Importantly, all six of the “subtype E” viruses analyzed
(90CR402.1 and 93TH253.3 as well as four additional isolates
from Thailand) fell into one cluster, with Thai strains again
grouping most closely (Fig. 2A). These results indicate that the
LTR region of “subtype E” viruses is not derived from subtype
A but instead likely of true subtype E origin, as are env and vif
regions. Phylogenetic trees from 59 and 39 nef regions sug-
gested that the 59 boundary of this E portion coincides with the
beginning of the LTR (data not shown). The 39 boundary could
not be determined, because in trees from 39 LTR sequences
the various subtypes no longer formed distinct monophyletic
groupings, thus making subtype classification impossible (data
not shown). However, the ambiguous region was very small,
including only the 39 half of R, U5, and a portion of the
untranslated leader sequence.
Summary of phylogenetic and breakpoint analyses. Com-
bining the results of Fig. 2 to 5, we have generated a composite
representation of the “subtype E” genome structure (Fig. 6).
This composite suggests that “subtype E” viruses are complex
hybrids of subtypes A and E. There are eight apparent points
of crossover, delineating eight alternating fragments of sub-
types A and E. Most of the LTR, the portion of env which
encodes gp120 and the extracellular domain of gp41, and the 39
half of nef are comprised of subtype E. The remainder of the
genome, including all of gag and pol, vpu, as well as both exons
of tat and rev, derive from subtype A. The vif and vpr regions
are multiply mosaic, which is consistent with frequent template
switches during the recombination event (10, 11). Some re-
gions and breakpoints, including the 39 LTR and the 59 and 39
boundaries of the subtype E envelope domain (Fig. 6), could
not be defined. Finally, both Thai and CAR “subtype E”
strains exhibited the same pattern of mosaicism, indicating that
they are derived from a common A/E recombinant ancestor.
Is the hybrid appearance of “subtype E” viruses an artifact?
The discordant phylogenetic positions of the different subtype
“E” genomic regions are most simply explained as the result of
recombination between ancestral subtype A and E viruses.
However, the lack of an example of a full-length (nonrecom-
binant) subtype E virus has led to speculation that the discor-
dant phylogenetic positions of gag and env sequences could be
due to large differences in the rates and/or patterns of evolu-
tion in these genes. Since most of the “subtype E” genome is
FIG. 5. Phylogenetic relationships of LTR sequences. A tree was constructed
from partial LTR sequences, including most of U3 and R (positions 93 to 548 of
the LTR alignment). Newly generated reference sequences for subtypes A to G
are shown in boxes (sequences were determined without interim cloning directly
from PCR amplification products).
FIG. 6. Inferred structure of the “subtype E” genome. A composite picture summarizing the results of diversity and bootstrap plots, as well as phylogenetic tree
analyses, is shown (see Fig. 2 to 5). Regions of subtype A and subtype E origin are indicated in blue and red, respectively; uncertain breakpoints (in env) and regions
that could not be subtyped (39 LTR) are represented by hatched boxes.
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actually A-like, we would have to infer that it is the env gene of
“subtype E” viruses that has evolved in an extraordinary fash-
ion.
For the env sequences of “E” viruses to fall so far outside the
A clade in the phylogenetic tree, one would have to imagine
that the “E” env genes have evolved extremely fast. However,
a simple acceleration of evolutionary rate in “subtype E” env
would not alone be sufficient to move this cluster of viruses
outside the subtype A clade. Rather, such an acceleration
would just be expected to lead to longer branches (as has been
reported for a strain of HIV-2 that had undergone G-to-A
hypermutation [27]). To move the “E” lineage to its present
position outside of the A clade would require that a substantial
fraction of the substitutions in “E” viruses subsequent to their
divergence from subtype A was convergent on the other sub-
types. Such a degree of sequence convergence is unprece-
dented. Nevertheless, it could be argued that HIV-1 env se-
quences are under extraordinary selection pressures and that
therefore such a degree of convergence is possible. However, if
that were the case, then selection should primarily target the
protein sequence and should have little (if any) effect on syn-
onymous substitutions. To examine this possibility directly, we
performed separate phylogenetic analyses for gag and env se-
quences based on numbers of synonymous and nonsynony-
mous substitutions. The phylogenetic trees obtained for syn-
onymous changes (Fig. 7) were very similar to those obtained
for all sequence substitutions (Fig. 2). In particular, the dis-
crepancy between the phylogenetic positions of “subtype E”
sequences in gag and env trees was just as striking (Fig. 7).
Phylogenetic trees based on nonsynonymous changes were also
very similar (not shown). Thus, all nucleotide substitutions in
subtype E env sequences, whether silent or amino acid replac-
ing, yielded the same phylogenetic relationships to the other
subtypes. On the basis of these results, we rule out the possi-
bility that disproportionate selection-driven evolution can ex-
plain the discordant phylogenetic position of “subtype E” env
gene sequences and thus conclude that “subtype E” viruses
represent intersubtype recombinants.
Analysis of regulatory regions in the “subtype E” LTR.
Phylogenetic analyses of LTR sequences (Fig. 5) revealed sep-
arate clustering of subtype A and “E” viruses, indicating that in
this part of the genome, “subtype E” viruses were distinct from
subtype A (Fig. 6). Because the LTR plays an essential role in
the regulation of viral gene expression (for reviews, see refer-
ences 28 and 44), we were interested to see if there were
subtype-specific differences in regions of known regulatory
function. Figure 8 depicts an LTR sequence alignment in the
core enhancer/promoter domain, spanning the region between
NF-kB and TAR elements. This alignment revealed several
sequence motifs in transcription factor binding regions that
were unique to members of “subtype E”. For example, all
“subtype E” viruses exhibited sequence changes in the distal
(59) NF-kB site (59-AGGACTTCC-39) which differed from the
consensus (59-GGGRNNYYCC-39 [68]) by both a transition at
the 59 end and a single nucleotide deletion. None of the other
viruses exhibited these types of changes; instead, most strains
FIG. 7. Phylogenetic analyses for gag and env sequences based on numbers of synonymous substitutions. Trees were midpoint rooted by using RETREE from the
PHYLIP (19) package (see the legend to Fig. 2 and Results for more details).
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contained at least two, and sometimes three, copies of the
consensus NF-kB domain. Subtype-specific sequence changes
were also observed in the TATA domain, in which “subtype E”
viruses exhibited TAAAA. All other strains of HIV-1 or
SIVCPZ displayed the sequence TATAA.
Sequence changes were also noted in the TAR element,
which is known to form a stable RNA stem-loop structure at
the 59 end of the viral RNA essential for Tat-mediated trans-
activation of HIV-1 gene expression (20, 28, 44, 71, 87). In
contrast to most HIV-1 and SIVCPZ strains, “subtype E” vi-
ruses were found to contain only two (instead of three) nucle-
otides in the bulge of this structure (Fig. 8 and 9). Interestingly,
the only other HIV-1 strains which contained such a two-
nucleotide bulge were members of subtype A (all five isolates
analyzed) and HIV-1MAL, a recombinant composed of sub-
types A and D (1, 85). This finding raised the possibility that
FIG. 8. Alignment of HIV-1/SIVCPZ LTR sequences surrounding the core enhancer region. Newly derived LTR sequences (indicated by asterisks) are compared
with previously published HIV-1 and SIVCPZ sequences from the database (75). Putative binding sites for transcription factors NF-kB, Sp1, and TATA, as well as
functional motifs within the TAR domain, are indicated. Subtype-specific sequence motifs referred to in the text are shaded. Periods indicate gaps introduced to
optimize the alignments. Sequences within a subtype are compared with a consensus sequence. Question marks in the consensus sequence indicate sites at which fewer
than 50% of the viruses have the same nucleotide.
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the two-nucleotide bulge was functionally linked to other viral
genes common to “subtype E” or A viruses. To examine this
possibility more closely, we compared the predicted secondary
structure of the “subtype E” TAR region (90CR402.1) with
those of subtype B (HXB2) and subtype A (U455) (Fig. 9).
This analysis revealed that the observed sequence changes did
not appear to affect the predicted stem-loop structure, since
the calculated energy values were very similar for all three
viruses (see the legend to Fig. 9). Moreover, regions of known
functional importance (28, 44, 87), such as the uridine residue
at position 123 and the composition of the stem between the
bulge and the terminal loop, were highly conserved. However,
there were differences between subtype A and E TAR se-
quences, which included substitutions in the stem as well as in
the terminal loop (circled in Fig. 9). Importantly, all six “sub-
type E” strains contained these same substitutions.
Given the high degree of sequence and structural conserva-
tion of TAR among the various HIV-1 and SIVCPZ strains
(Fig. 8), the lack of a third nucleotide in the TAR bulge of
“subtype E” and A viruses is quite remarkable. Subtype A and
FIG. 8—Continued.
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“E” TAR elements are obviously functional, since the se-
quence changes in the bulge are present in five of five subtype
A and six of six “subtype E” viruses. Moreover, it is intriguing
that the only viruses known to have a two-nucleotide TAR
bulge, apart from members of subtype A, are MAL and mem-
bers of “subtype E,” all of which are recombinants containing
genomic regions derived from subtype A. Because most of the
“subtype E” LTR is clearly not of subtype A origin but likely
represents subtype E (Fig. 5), the lack of the third nucleotide
in the TAR bulge could represent a compensatory change, i.e.,
a deletion that occurred after recombination brought together
a subtype E LTR with subtype A coding regions. This, in turn,
would suggest that a functional link exists between the two
nucleotide bulge and a subtype A protein. The most obvious
candidate for such a protein would of course be Tat, since this
protein is known to bind the bulge region of TAR directly (28,
44). Moreover, both in subtype A and “E” viruses, tat gene
sequences are derived from subtype A (both first and second
exons [Fig. 6]). However, this hypothesis is not consistent with
the presence of a two-nucleotide bulge in MAL (Fig. 8), which
contains a subtype D tat gene (85), or the presence of a three-
nucleotide bulge in another HIV-1 strain, termed IBNG,
whose sequence was recently reported to represent subtype A
(75).
To investigate further whether there is a correlation between
the presence of a two-nucleotide TAR bulge and a particular
genomic region different from tat in subtype A viruses, we
analyzed the sequences of MAL and IBNG more closely. In
particular, we were interested in coding regions where MAL
was A-like (because it contains the two-nucleotide bulge) but
IBNG was not (because it contains a three-nucleotide bulge).
Bootstrap plots were generated similar to the ones shown in
Fig. 3, except that this time MAL and IBNG were included in
the tree analyses and their phylogenetic positions relative to
representatives of subtype A (U455 and 90UG037.1) were
examined (Fig. 10). This analysis confirmed that both IBNG
and MAL contained sequences of subtype A origin and, in
addition, revealed that IBNG was recombinant. As shown in
Fig. 10A, most of the IBNG genome appears to derive from
subtype A. However, bootstrap values were very low in 39 gag,
59 pol, vif, and parts of env, strongly suggesting recombination
with another subtype (this may be subtype G, since IBNG
groups with subtype G viruses in the LTR [Fig. 5]). Similarly,
MAL was found to contain subtype A sequences in the 59 gag,
39 pol, and 59 nef regions (Fig. 10B), in agreement with previ-
ous results (85). However, bootstrap plots revealed one addi-
tional small subtype A peak in the 59 pol domain that had
previously gone unrecognized. The remainder of the MAL
genome, except for the middle of pol, which cannot be classi-
fied (85), represented subtype D (bootstrap plots evaluating
the position of MAL relative to subtype D viruses were per-
formed but are not shown). Taken together, these analyses
identified only a single region where MAL clustered in subtype
A but IBNG did not (horizontal arrows in Fig. 10A and B).
This region mapped to a 59 pol domain which encodes parts of
the protease and RT. Thus, if there is indeed a functional link
between a two-nucleotide TAR bulge and a subtype A protein,
we would predict the latter to be encoded by the 59 region of
the pol gene.
DISCUSSION
“Subtype E” viruses represent A/E intersubtype recombi-
nants. In this study, we used a variety of complementary ana-
lytical strategies to explore the genetic identity and evolution-
ary origins of “subtype E” viruses. Using diversity and
bootstrap plots in combination with phylogenetic tree analyses,
we found that most of the “subtype E” genome, including the
gag, pol, tat, rev, vpu, and 59 nef regions, is actually composed of
subtype A-derived sequences. However, the extracellular por-
tion of env, parts of vif and vpr, and most of the LTR are not
of subtype A origin. Unless there have been additional recom-
bination events with unidentified subtypes during the evolution
of these viruses, all of the latter genomic regions must be
derived from subtype E. vif and vpr regions were found to be
multiply mosaic, which is consistent with template switches of
the RT during proviral DNA synthesis and thus highly sugges-
tive of recombination (10, 11). Nevertheless, because it had
been suggested that the discordant phylogenies between dif-
ferent “subtype E” genes may be the result of unusual patterns
of evolution, we examined this question by constructing sepa-
rate phylogenetic trees for synonymous and nonsynonymous
substitutions. We found no differences in the relative positions
of “subtype E” gag and env gene sequences. Thus, there is no
evidence for selection-driven convergent evolution as an ex-
planation for the discordant branching orders of “subtype E”
gag and env sequences. Finally, we identified subtype-specific
sequence motifs in the viral LTR (in NF-kB and TATA do-
mains) that distinguished the “E” clade viruses from all others,
including members of subtype A. Based on these findings, we
conclude that “subtype E” viruses are in fact recombinants of
subtypes A and E. Similar conclusions have recently been
reached by other investigators (8) who analyzed a second Thai
“subtype E” strain (CM240). However, our findings of at least
eight points of recombination crossover, the characterization
of a second full-length subtype A reference sequence, separate
analyses of synonymous and nonsynonymous nucleotide sub-
stitutions, and the identification of signature sequences in the
“subtype E” LTR distinguish the present report.
The timing and circumstances of the recombination event
that generated the subtype A/E viruses are unknown. How-
ever, several lines of evidence suggest that it took place in
Central Africa. Thai and CAR strains (93TH253.3 and
90CR402.1) analyzed in this study exhibited the same pattern
of mosaicism, indicating that they are derived from the same
recombinant ancestor. Since subtype A viruses have not been
identified in Thailand (despite extensive sampling), the recom-
bination event most likely occurred in Central Africa, where
FIG. 9. Secondary structure comparison of TAR RNA sequences from mem-
bers of subtype B (HXB2), subtype A (U455), and “subtype E” (90CR402.1).
Secondary structures were predicted using the MFold and PlotFold programs of
the University of Wisconsin Genetics Computer Group software package. The
predicted free energy values are 225.5 kcal (1 cal 5 4.184 J)/mol for HXB2,
225.2 kcal/mol for U455, and 224.3 kcal/mol for 90CR402.1. The nucleotides
comprising the TAR bulge in the different viruses are shaded. Nucleotide dif-
ferences which distinguish subtype A and subtype E TAR sequences are circled.
7024 GAO ET AL. J. VIROL.
members of both subtype A and “E” are known to exist (72,
78). At some point after that recombination event, a descen-
dant virus was introduced into the Thai population, where it
then spread with extraordinary rapidity (111, 112). The fate of
the nonrecombinant (ancestral) subtype E parental strain re-
mains unknown. It is possible that viruses of this subtype still
exist but have not yet been identified. Alternatively, the orig-
inal subtype E lineage may have become extinct, with its only
remaining vestige residing in the present day A/E recombi-
nants.
The realization that “subtype E” viruses represent A/E re-
combinants has obvious practical implications for subtype no-
menclature and the identification of new subtypes. In the past
several years, subtype classification has become a critical tool
for molecular epidemiologists since it provides a means to
monitor the geographic distribution, prevalence, and intermix-
ing of globally circulating HIV-1 variants (113). In addition,
subtype classification has served as the basis for the identifi-
cation of intersubtype recombinants (34, 91, 99), thereby alert-
ing the scientific community to the existence of coinfection of
individuals by more than one virus strain. It thus defeats the
purpose to classify hybrid viruses as distinct subtypes, even if
they all exhibit the same pattern of mosaicism. For this reason,
we propose to reclassify “subtype E” viruses as A/E recombi-
nants. The term “subtype E” should be reserved for genomic
regions within A/E viruses which are of true subtype E origin.
This will also avoid unnecessary confusion should nonrecom-
binant examples of subtype E eventually be identified. The
FIG. 10. Bootstrap plots depicting the relationship of IBNG (A) and MAL (B) to subtype A viruses. Regions within the IBNG and MAL genome that are of subtype
A origin (as determined from the bootstrap plots) are shown as filled areas. A horizontal arrow denotes the 59 pol domain which correlates with the size of the TAR
bulge. See the legend to Fig. 3 and Results for more details.
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example of the “subtype E” recombinants also illustrates a
problem inherent in the designation of new subtypes (several
candidates have recently been identified [55, 75]). Ideally, a
new subtype should be designated only after a representative
isolate has been sequenced in its entirety and its genome struc-
ture has been examined for evidence of mosaicism. Unfortu-
nately, the amount of work involved and the lack of reference
sequences even for the currently known subtypes make this
impractical, at least at the present time. However, at a mini-
mum, analysis of full-length gag and env sequences should be
required for the designation of any new subtype candidate.
This would exclude most hybrid viruses, since the majority
contain at least one crossover within these regions or an odd
number of crossovers between gag and env such that these
sequences fall into different subtypes (86). It is also probably
desirable to have such sequence data for several epidemiolog-
ically unlinked representatives, thus reserving subtype names
for strains of epidemiological significance.
Full-length reference sequences are needed for the phyloge-
netic classification of HIV-1. Since intersubtype recombinants
are being recognized with increasing frequency (15, 16, 25, 56,
85, 86, 88, 91, 99), HIV-1 subtype reference sequences for
regions outside of gag and env are critically needed to examine
newly derived viruses for evidence of mosaicism. For example,
in this study we were unable to determine the subtype assign-
ment of the regions in IBNG which did not cluster with subtype
A. Similarly, classification of “subtype E” LTR sequences was
possible only after appropriate reference sequences were gen-
erated for phylogenetic analyses. Finally, a second subtype A
reference sequence was required to confirm the breakpoint
analyses from diversity and bootstrap plots for the “subtype E”
genome. To begin to define the true impact of intersubtype
recombination on global HIV variation, it is thus necessary to
derive full-length reference sequences for all HIV-1 group M
subtypes.
There are several approaches to generate full-length HIV-1
genomes, including lambda phage cloning, long PCR, or PCR
amplification of proviral halves. All of these have shortcom-
ings, particularly if the product is intended as a biological
reference strain. Lambda phage techniques allow cloning of
viral genomes as single genomic units and are not subject to
PCR misincorporations or other polymerase-induced artifacts
(including recombination). However, this method depends on
efficient virus growth in tissue culture or requires screening of
vast numbers of recombinant phage clones, as was the case for
90CR402.1. Adaptation of viruses to growth in immortalized
T-cell lines can overcome low viral titers but may also select for
variants with altered biological properties (53, 70). Thus, un-
less an isolate replicates with reasonable efficiency in primary
target cells, long PCR and PCR amplification of proviral halves
are probably more appropriate methods of deriving full-length
proviruses. Nevertheless, biological reference reagents are still
best derived by lambda phage approaches, even if isolated
proviruses require subsequent reconstruction to yield a biolog-
ically active genome (we are currently restoring the vif gene in
90CR402.1 in an attempt to generate a replication-competent
reference clone for this primary “subtype E” isolate).
A/E recombinants from Thailand and the Central African
Republic exhibit unique sequence changes in the core enhanc-
er/promoter region of their LTR. Inspection of the core en-
hancer/promoter sequences among members of all HIV-1
groups and subtypes revealed a number of interesting features,
particularly for members of “subtype E”. For example, all “E”
viruses exhibited unique sequence changes in their 59 (distal)
NF-kB sites, differing from the consensus both in a nucleotide
substitution and a single base pair deletion. It is possible that
these changes reduce the binding of the NF-kB transcription
factor and thus influence gene expression. Alternatively, there
may not be any appreciable effect on NF-kB binding, since
there are enhancer domains in the human genome which con-
tain comparable changes in their NF-kB domain (for a review,
see reference 68). Without direct experimentation, it is thus
impossible to predict whether the observed sequence changes
in “subtype E” NF-kB or TATA regions have biological con-
sequences. Nevertheless, the sequence changes are present in
all isolates, including the distantly related 90CR402.1 strain,
and thus represent subtype specific signatures of “subtype E”
viruses.
LTR sequence alignments also revealed that a subset of
HIV-1 strains exhibited an unusual TAR element. Figure 8
shows that all isolates of subtype A and “subtype E,” and one
A/D hybrid strain of HIV-1 (MAL), contain a TAR sequence
predicted to have a two-nucleotide bulge. All other HIV-1
strains (including members of group O) as well as all known
SIVCPZ isolates contain a three-nucleotide TAR bulge. This
extent of conservation among otherwise highly divergent vi-
ruses strongly suggests that changes in the size of the TAR
bulge are generally not tolerated. Moreover, since the only
viruses shown to have a two-nucleotide bulge were either mem-
bers of subtype A or recombinants containing genomic regions
derived from subtype A, we speculated that there might be a
functional link between the two-nucleotide bulge and a sub-
type A protein. A recombination event bringing together the
gene for such a subtype A protein with a non-subtype A LTR
might be expected to select for a compensatory change (i.e.,
deletion of the third bulge nucleotide) to restore optimal in-
teraction. A candidate coding region was identified in the 59
pol gene by mapping IBNG (Fig. 10).
Recent experimental evidence (36) supports the possibility
of a TAR-polymerase interaction. Expressing TAR mutant
HIV-1 proviruses in the presence of adenovirus E1A and E1B
proteins (which complement for the lack of transcriptional
activation by Tat), Harrich et al. identified several TAR point
mutants which did not substantially alter viral gene expression
but led to greatly diminished levels of strong stop DNA syn-
thesis (36). These results suggest that TAR, in addition to
playing an important role in Tat-associated transactivation, is
essential for initial steps in HIV-1 reverse transcription. More-
over, the structure of the TAR stem-loop was found to be
important for this activity (36). TAR thus appears to interact
(directly or indirectly) with components of the initiation com-
plex, which includes the p66-p51 RT heterodimer. These find-
ings are consistent with our observation of an association be-
tween the TAR bulge size and the phylogenetic subtype of the
corresponding 59 pol region. It is also consistent with the mo-
saic genome structure of SIV infecting West African sabaeus
monkeys (43). While these viruses cluster with SIVAGM from
other green monkey species in trees derived from the 39 halves
of their genomes, they group with the HIV-2/SIVSM lineage in
trees based on the 39 half of gag and the 59 half of pol. Most
interestingly, sabaeus monkey viruses also contain a duplica-
tion of their TAR element, a feature unique to members of the
HIV-2/SIVSM lineage (4, 21). Thus, in both HIV-1 and
SIVAGM/SIVSM hybrids, there is an association between the
structure of the TAR element and the phylogenetic origin of
the 59 pol region. Together with the experimental results by
Harrich et al. (36), these findings argue for a functional inter-
action between RT and TAR and suggest a preference for a
two-nucleotide TAR bulge by the subtype A RT.
Intersubtype recombination represents an important new
source of HIV-1 variation. Recombination provides the oppor-
tunity for evolutionary leaps, as its genetic consequences are
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far more dramatic than the steady accumulation of individual
mutations. In this context, it is of interest that the “subtype E”
epidemic in Thailand has a number of unique features. Most
importantly, “subtype E” viruses are spreading with extraordi-
nary rapidity (111, 112). Introduced in the late 1980s along
with subtype B viruses, “E” viruses comprise the great majority
of HIV-1 infections in Thailand today (13, 81, 111, 112). More-
over, there is evidence of increasing spread of “subtype E”
viruses to surrounding countries (112) as well as to the western
hemisphere (2, 7). Finally, “subtype E” viruses are transmitted
largely through heterosexual contact (46, 52, 66, 77, 79, 82).
Although this may be due in part to epidemiological factors, it
may also be the result of particular viral properties. The recent
report of preferential growth of “subtype E” viruses in Lang-
erhans cells (103), which are believed to constitute the first line
of target cells following mucosal transmission (104), could ex-
plain the (preferential) epidemic spread of “subtype E” viruses
in Thailand. It is presently unknown whether the mosaic ge-
nome structure of “subtype E” viruses has any relation to these
unusual biological properties. However, examples of recombi-
nation events in HIV and other retroviruses indicate that this
process can generate viral variants with significantly altered
biological properties (9, 30, 48, 107). Thus, a link between the
hybrid origin of “subtype E” viruses and their success as an
epidemic pathogen must be considered.
Finally, it should be emphasized that intersubtype recombi-
nation appears to represent a relatively recent phenomenon.
The various HIV-1 subtypes must have evolved in relative
isolation from each other for some time, or their members
could not have accumulated the number of distinctive changes
that now characterize them as discrete subtypes. Then, with
epidemic spread and mixing of clades, the opportunity for
coinfection and recombination was created. A recent example
of this occurred in Brazil, where subtype B and F recombinants
have been generated (25, 88). With the population density of
the different subtypes still increasing in many countries (42, 75,
78, 113), additional recombinants are likely to be generated.
The widespread dissemination and obvious virulence of “sub-
type E” viruses indicate that intersubtype recombination can
generate potent pathogens. As correlates of immune protec-
tion arising from natural infection and vaccines are identified,
it will be critically important to assess the effects of viral re-
combination on virus-host interaction. In this context, continu-
ing surveillance of HIV-1 variation worldwide will be essential.
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